Search & Filter

An extended course of hormone therapy after treatment could prevent the recurrence of breast cancer in postmenopausal women with early breast cancer, new data presented at the American Society of Clinical Oncology (ASCO) Annual Meeting has revealed.

Saxenda (liraglutide) could benefit patients with prediabetes and obesity to help them achieve weight loss and improve cardiometabolic risk factors, data from the Phase 3 SCALE (Satiety and Clinical Adiposity €“ Liraglutide Evidence) Obesity and Prediabetes trial has revealed.

The findings of the HOPE-3 trial have the potential to both change and reinforce current clinical practice for primary prevention for patients at intermediate-risk of developing cardiovascular disease. 

The risk of developing aggressive prostate cancer can be worsened by being an unhealthy weight and having a large waistline, a study has found.

Data showed remission and response rates of 37.2% and53.2% respectively at week 12 in refractory ulcerative colitis (UC) patientstreated with Adacolumn

The European Commission (EC) has approved the use of paliperidone palmitate (TREVICTA) €“ a 3-monthly injection €“ for the maintenance treatment of schizophrenia in adult patients.

Data presented at the Digestive Disease Week meeting in San Diego supports the use of Adacolumn in certain patients with moderate-to-severe, steroid-dependent active ulcerative colitis (UC).

An estimated 475,000 hospital admissions were attributed to smoking in 2014-15, a rise of 23,000 (5%) in the past 10 years, according to new figures released by the Health and Social Care Information Centre.

A treatment option for metastatic hormone-relapsed prostate cancer (mHRPC) cabazitaxel (Jevtana) has been recommended for use in combination with prednisone or prednisolone in England following a review by NICE.

Over twice the number of older people than previously thought may be left waiting in hospital despite being ready for discharge, according to a National Audit Office (NAO) report today.

Despite policy pressure on GPs to offer consultations by email or internet video programmes such as Skype, few GPs do and most have no plans to introduce them in future, according to a new study.

NICE has recommended cabazitaxel (Jevtana) for the treatment of metastatic hormone-relapsed prostate cancer (mHRPC) in England, pharma Sanofi Genzyme has announced.

One in four patients develop heart failure within four years of a first heart attack, according to a study in nearly 25 000 patients presented at Heart Failure 2016 and the 3rd World Congress on Acute Heart Failure.

Exercise is associated with a longer life in patients with heart failure, according to analysis of more than 4,000 patients, which showed a mortality benefit from exercise regardless of heart failure severity, age and gender.

Levels of obesity in the population increase with age until around 70 years, after which prevalence declines due to a number of factors including concurrent illness. This articles looks at management of obesity in the older patient.